NICE isn’t being so nice to anti-TNF drugs. The UK’s National Institute for Health and Clinical Excellence, which evaluates the cost-effectiveness of medications, said it doesn’t support a second try with another one of several big-selling drugs for rheumatoid arthritis after a patient has failed treatment with a different medicine in the class.
It’s a blow [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment